Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Gross Profit (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Gross Profit for 6 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 85.17% year-over-year to $1.3 million, compared with a TTM value of $13.5 million through Dec 2025, down 76.55%, and an annual FY2025 reading of $28.1 million, down 9.55% over the prior year.
  • Gross Profit was $1.3 million for Q4 2025 at Roivant Sciences, down from $1.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $37.6 million in Q4 2021 and bottomed at $1.3 million in Q4 2025.
  • Average Gross Profit over 5 years is $12.9 million, with a median of $7.8 million recorded in 2024.
  • The sharpest move saw Gross Profit soared 1150.99% in 2021, then crashed 88.5% in 2024.
  • Year by year, Gross Profit stood at $37.6 million in 2021, then plummeted by 64.14% to $13.5 million in 2022, then skyrocketed by 174.34% to $36.9 million in 2023, then tumbled by 76.29% to $8.8 million in 2024, then tumbled by 85.17% to $1.3 million in 2025.
  • Business Quant data shows Gross Profit for ROIV at $1.3 million in Q4 2025, $1.5 million in Q3 2025, and $2.0 million in Q2 2025.